Preventing Mitochondrial Diseases: Embryo-Sparing Donor-Independent Options
Authors:
- 28 March 2018
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 24 (5) , 449-457
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Mitochondrial Replacement, Evolution, and the ClinicScience, 2013
- Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variantsNature, 2012
- Human mitochondrial DNA: roles of inherited and somatic mutationsNature Reviews Genetics, 2012
- Towards germline gene therapy of inherited mitochondrial diseasesNature, 2012
- Rapid Mitochondrial DNA Segregation in Primate Preimplantation Embryos Precedes Somatic and Germline BottleneckCell Reports, 2012
- UNCERTAIN TRANSLATION, UNCERTAIN BENEFIT AND UNCERTAIN RISK: ETHICAL CHALLENGES FACING FIRST‐IN‐HUMAN TRIALS OF INDUCED PLURIPOTENT STEM (IPS) CELLSBioethics, 2011
- Ethics of modifying the mitochondrial genomeJournal of Medical Ethics, 2010
- Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA diseaseNature, 2010
- Asexual healingNature, 2009
- Gene therapy for progeny of mito-mice carrying pathogenic mtDNA by nuclear transplantationProceedings of the National Academy of Sciences, 2005